AU2003301851A1 - Azacyclic compounds as orexin receptor antagonist - Google Patents
Azacyclic compounds as orexin receptor antagonistInfo
- Publication number
- AU2003301851A1 AU2003301851A1 AU2003301851A AU2003301851A AU2003301851A1 AU 2003301851 A1 AU2003301851 A1 AU 2003301851A1 AU 2003301851 A AU2003301851 A AU 2003301851A AU 2003301851 A AU2003301851 A AU 2003301851A AU 2003301851 A1 AU2003301851 A1 AU 2003301851A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonist
- orexin receptor
- azacyclic compounds
- azacyclic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0225884.6A GB0225884D0 (en) | 2002-11-06 | 2002-11-06 | Novel compounds |
| GB0225884.6 | 2002-11-06 | ||
| PCT/EP2003/012403 WO2004041816A1 (en) | 2002-11-06 | 2003-11-04 | Azacyclic compounds as orexin receptor antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003301851A1 true AU2003301851A1 (en) | 2004-06-07 |
Family
ID=9947317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003301851A Abandoned AU2003301851A1 (en) | 2002-11-06 | 2003-11-04 | Azacyclic compounds as orexin receptor antagonist |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003301851A1 (en) |
| GB (1) | GB0225884D0 (en) |
| WO (1) | WO2004041816A1 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0400405A3 (en) * | 2004-02-10 | 2009-03-30 | Sanofi Synthelabo | Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates |
| BRPI0508263B8 (en) | 2004-03-01 | 2021-05-25 | Idorsia Pharmaceuticals Ltd | 1, 2, 3,4-tetrahydro-isoquinoline derivatives, pharmaceutical composition, and use of 1, 2, 3,4-tetrahydro-isoquinoline derivative |
| CA2657623A1 (en) | 2006-07-14 | 2008-01-17 | Merck & Co., Inc. | Bridged diazepan orexin receptor antagonists |
| WO2008038251A2 (en) * | 2006-09-29 | 2008-04-03 | Actelion Pharmaceuticals Ltd | 3-aza-bicyclo[3.1.0]hexane derivatives |
| PE20081229A1 (en) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | DIAZEPAM OREXIN RECEPTOR ANTAGONISTS REPLACED |
| ATE496043T1 (en) | 2006-12-01 | 2011-02-15 | Actelion Pharmaceuticals Ltd | 3-HETEROARYL (AMINO OR AMIDO)-1- (BIPHENYL OR PHENYLTHIAZOLYL) CARBONYLPIPERDINE DERIVATIVES AS OREXIN RECEPTOR INHIBITORS |
| CL2007003827A1 (en) * | 2006-12-28 | 2008-09-26 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM N- (2-AZA-BICYCLE (3.1.0) HEX-3-ILMETIL) AMIDA; AND ITS USE TO PREVENT OR TREAT DEPRESSION, NEUROSIS, SCHIZOPHRENIA, ANXIETY, ADDICTIONS, EPILEPSY, PAIN, HEART DISEASES, AMONG OTHERS. |
| CL2008000836A1 (en) * | 2007-03-26 | 2008-11-07 | Actelion Pharmaceuticals Ltd | Thiazolidine derivative compounds, orexin receptor antagonists; pharmaceutical composition that includes them; and its use in the treatment of emotional neurosis, severe depression, psychotic disorders, Alzheimer's, parkinson's, pain, among others. |
| JP2010528007A (en) | 2007-05-23 | 2010-08-19 | メルク・シャープ・エンド・ドーム・コーポレイション | Cyclopropylpyrrolidine orexin receptor antagonist |
| EP2152690B1 (en) | 2007-05-23 | 2012-01-11 | Merck Sharp & Dohme Corp. | Pyridyl piperidine orexin receptor antagonists |
| CN101874028B (en) | 2007-07-27 | 2012-11-14 | 埃科特莱茵药品有限公司 | 2-aza-bicyclo[3.3.0]octane derivatives |
| WO2009040730A2 (en) | 2007-09-24 | 2009-04-02 | Actelion Pharmaceuticals Ltd | Pyrrolidines and piperidines as orexin receptor antagonists |
| JP2011512400A (en) | 2008-02-21 | 2011-04-21 | アクテリオン ファーマシューティカルズ リミテッド | 2-Aza-bicyclo [2.2.1] heptane derivatives |
| US20100144760A1 (en) * | 2008-12-02 | 2010-06-10 | Giuseppe Alvaro | Novel compounds |
| EP2370427A1 (en) * | 2008-12-02 | 2011-10-05 | Glaxo Group Limited | N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof |
| EP2504316A1 (en) | 2009-11-23 | 2012-10-03 | MSD Oss B.V. | Heterocylic compounds as antagonists of the orexin receptors |
| MX2012006909A (en) | 2009-12-29 | 2012-07-10 | Suven Life Sciences Ltd | α4î²2 neuronal nicotinic acetylcholine receptor ligands. |
| AR088352A1 (en) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE |
| SG11201404738QA (en) | 2012-02-07 | 2014-10-30 | Eolas Therapeutics Inc | Substituted prolines / piperidines as orexin receptor antagonists |
| US9440982B2 (en) | 2012-02-07 | 2016-09-13 | Eolas Therapeutics, Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
| ITMI20120424A1 (en) * | 2012-03-19 | 2013-09-20 | Rottapharm Spa | CHEMICAL COMPOUNDS |
| PT2855453T (en) | 2012-06-04 | 2017-03-09 | Actelion Pharmaceuticals Ltd | Benzimidazole-proline derivatives |
| AU2013328301A1 (en) | 2012-10-10 | 2015-05-28 | Actelion Pharmaceuticals Ltd | Orexin receptor antagonists which are [ortho bi (hetero-)aryl]-[2-(meta bi (hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives |
| CN105051040A (en) | 2013-03-12 | 2015-11-11 | 埃科特莱茵药品有限公司 | Azetidine amide derivatives as orexin receptor antagonists |
| UA119151C2 (en) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1 h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist |
| MA39163B1 (en) | 2013-12-03 | 2018-09-28 | Idorsia Pharmaceuticals Ltd | Crystalline form of (S) - (2- (6-chloro-7-methyl-1H-benzo [d] imidazol-2-yl) -2-methylpyrrolidin-1-yl) (5-methoxy-2- (2-h) 1,2,3-triazol-2-yl) phenyl) methanone and its use as orexin receptor antagonists |
| MX366642B (en) | 2013-12-04 | 2019-07-17 | Idorsia Pharmaceuticals Ltd | Use of benzimidazole-proline derivatives. |
| WO2016025669A1 (en) | 2014-08-13 | 2016-02-18 | Eolas Therapeutics, Inc. | Difluoropyrrolidines as orexin receptor modulators |
| WO2017139603A1 (en) | 2016-02-12 | 2017-08-17 | Astrazeneca Ab | Halo-substituted piperidines as orexin receptor modulators |
| WO2017194548A1 (en) | 2016-05-10 | 2017-11-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases |
| WO2020007964A1 (en) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives |
| WO2020099511A1 (en) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Benzimidazole-2-methyl-morpholine derivatives |
| TW202400149A (en) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2361390A1 (en) * | 1973-12-10 | 1975-06-19 | Merck Patent Gmbh | ISOCHINOLINE DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION |
| JP2786479B2 (en) * | 1989-05-31 | 1998-08-13 | 三田工業株式会社 | Image reading processor |
| MXPA02008797A (en) * | 2000-03-14 | 2005-09-08 | Actelion Pharmaceuticals Ltd | 1,2,3,4 tetrahydroisoquinoline derivatives. |
| EP1288202A4 (en) * | 2000-05-11 | 2003-07-02 | Banyu Pharma Co Ltd | N-ACYLTETRAHYDROISOCHINOLIN DERIVATIVES |
| US6677354B2 (en) * | 2000-06-16 | 2004-01-13 | Smithkline Beecham P.L.C. | Piperdines for use as orexin receptor antagonists |
-
2002
- 2002-11-06 GB GBGB0225884.6A patent/GB0225884D0/en not_active Ceased
-
2003
- 2003-11-04 AU AU2003301851A patent/AU2003301851A1/en not_active Abandoned
- 2003-11-04 WO PCT/EP2003/012403 patent/WO2004041816A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004041816A1 (en) | 2004-05-21 |
| GB0225884D0 (en) | 2002-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003301851A1 (en) | Azacyclic compounds as orexin receptor antagonist | |
| AP1828A (en) | Muscarinic Acetycholine receptor antagonists | |
| AU2003261392A1 (en) | M3muscarinic acetylcholine receptor antagonists | |
| AU2003241836A1 (en) | Lpa receptor antagonists | |
| AU2003231513A1 (en) | Pgd2 receptor antagonist | |
| SI2065384T1 (en) | Tricyclic thrombin receptor antagonist | |
| IL174538A0 (en) | Thrombin receptor antagonists | |
| AU2003300952A1 (en) | Indane compounds as ccr5 antagonists | |
| AU2002249275A1 (en) | Oxo azabicyclic compounds | |
| IL172822A0 (en) | Muscarnic acetylcholine receptor antagonists | |
| AU2003215549A1 (en) | Mercaptoimidazoles as ccr2 receptor antagonists | |
| AU2003255501A1 (en) | Cxcr4 receptor antagonists | |
| AU2002347552A1 (en) | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists | |
| AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
| AU2003287219A1 (en) | Il-8 receptor antagonists | |
| AU2003267802A1 (en) | Quaternary ammonium compounds as muscarinic receptor antagonists | |
| IL162534A0 (en) | Novel alkansulfonamides as endotheline antagonists | |
| AU2003242244A1 (en) | Chemokine receptor antagonist | |
| GB0215389D0 (en) | Receptor | |
| AU2003240730A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonist | |
| HK1092357A (en) | Muscarinic acetycholine receptor antagonists | |
| AU2002334103A1 (en) | Azabicyclic spiroether derivatives as receptor antagonists | |
| HK1086837A (en) | Thrombin receptor antagonists | |
| AU2002240149A1 (en) | Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists | |
| HK1089662A (en) | Muscarinic acetylcholine receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |